While our study and others have implicated SETX as a key factor in supporting cancer cell fitness, suggesting its potential as a therapeutic target, it’s crucial to acknowledge the evidence that SETX can also act as a tumor suppressor in specific contexts [23, 29]. The gene discussed is SETX; the disease is cancer.